Advances in medicine often depend on the effective collection, storage, research use, and sharing of human biological specimens and associated data. But what about the sources of such specimens? When a blood specimen is drawn from a vein in your arm, is that specimen still you? …
"From the late fifteenth century to the present day, countless explorers, conquerors, and other agents of empire have laid siege to the New World, plundering and pilfering its most precious artifacts and treasures. Today, these natural and cultural products--which are key to con…
Over the past 25 years, biobanks of human specimens have become a cornerstone for research on human health and have empowered the omics revolution that characterizes biomedical science in the 21st Century. Today, biobanking of human specimens is a critical component of the inter…
by Rand Infrastructure, Safety, and Environment (Organization), Transportation, Space, and Technology Program (Rand Corporation), Eiseman, Elisa, National Cancer Institute (U.S.), Rand Corporation
fromDocumented briefing (Rand Corporation)
The National Cancer Institute (NCI) Office of Biorepositories and Biospecimen Research (OBBR) asked the RAND Corporation to identify and analyze existing data on the effects of preanalytical variables on biospecimens used to study genetic and proteomic changes in cancer. The pro…
by Rand Infrastructure, Safety, and Environment (Organization), Transportation, Space, and Technology Program (Rand Corporation), Eiseman, Elisa, National Cancer Institute (U.S.), Rand Corporation
fromDocumented briefing (Rand Corporation)
The National Cancer Institute (NCI) Office of Biorepositories and Biospecimen Research (OBBR) asked the RAND Corporation to identify and analyze existing data on the effects of preanalytical variables on biospecimens used to study genetic and proteomic changes in cancer. The pro…
by Rand Infrastructure, Safety, and Environment (Organization), Transportation, Space, and Technology Program (Rand Corporation), Eiseman, Elisa, Rand Corporation, National Cancer Institute (U.S.)
fromDocumented briefing (Rand Corporation)
The National Cancer Institute (NCI) Office of Biorepositories and Biospecimen Research (OBBR) asked the RAND Corporation to identify and analyze existing data on the effects of preanalytical variables on biospecimens used to study genetic and proteomic changes in cancer. The pro…
The National Cancer Institute (NCI) Office of Biorepositories and Biospecimen Research (OBBR) asked the RAND Corporation to identify and analyze existing data on the effects of preanalytical variables on biospecimens used to study genetic and proteomic changes in cancer. The pro…
